Supportive Care Clinical Trials

Protocol Description Setting Population

Merck V212-011

A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy

Any Stage

Inactivated Shingles Vaccine; patient must not be receiving or scheduled to receive Rituxan

Amgen 20070782

A randomized, double-blind, placebo-controlled study to evaluate the long-term safety and efficacy of darbepoetin alfa adminstered at 500ug once q. 3 weeks in anemic subjects with advanced NSCLC receiving multi-cycle chemotherapy

Supportive Care

Stage 3b-4, receiving first line chemo, hgb < 11


If you have any question on your eligibility for any of these trials or any general questions please feel free to contact our Clinical Research Coordinator at 773-665-9837(P), or fax at 773-665-6890.

Call 877-RES-INFO for Nurse Advice, Doctor Referrals or Class Registration Monday - Friday 8 am to 8 pm • Weekends 8 am to 4pm

Special Features

  • Top cardiovascular hospital

    Recognized as a 2014 Top 50 Cardiovascular Hospital by Truven Health Analytics. Learn more.

  • Accreditation Earned

    Chicago Institute of Advanced Bariatrics earns national accreditation from the ACS.

  • Academic Center of Excellence

    Named an Academic Center of Excellence by the American Institute of Minimally Invasive Surgery. Learn more.

  • We need your voice!

    Our legislators are tackling issues that impact on our ability to live our mission. Learn more »

For Your Good Health

  • Stories of Patient Care

    Find out what our patients are saying about us here at Saint Joseph Hospital.

Saint Joseph Hospital has gone social